HEMO-GE.ApS: Financial statements 2025
CVR: 39076322
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
HEMO-GE.ApS (CVR 39076322) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -6,000 and a net result of DKK 90,958 compared with DKK 96,416 the year before. Equity in the 2025 report amounted to DKK 4,326,266. The solvency ratio was 97%.
- Gross Profit
- DKK -6,000
- Profit/Loss
- DKK 90,958
- Equity
- DKK 4,326,266
- Total Assets
- DKK 4,459,369
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -6 t. | 91 t. | 4.3 mio. | 0 |
| 2024 | - | -6 t. | 96 t. | 4.4 mio. | 0 |
| 2023 | - | -5 t. | 2.5 mio. | 4.4 mio. | - |
| 2022 | - | -6 t. | 124 t. | 2 mio. | - |
| 2021 | - | -4 t. | 96 t. | 2 mio. | - |
Official annual report
How creditworthy is HEMO-GE.ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
HEMO-GE.ApS has published its annual report for 2024. Gross profit came to DKK -5,711, and the net result was DKK 96,416.
About HEMO-GE.ApS
HEMO-GE.ApS is a Danish company of the type Anpartsselskab based in Rudkøbing, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Graakjær Eriksen. The company is owned by Henrik Graakjær Eriksen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,000 and a net result of DKK 90,958 compared with DKK 96,416 the year before. Equity in the 2025 report amounted to DKK 4,326,266.